67 results on '"Felker, G"'
Search Results
2. Natriuresis-Guided Titration of Loop Diuretics in Heart Failure: Another Brick in the Wall
3. Heart Failure Across the Range of Mildly Reduced and Preserved Ejection Fraction in the United States
4. Clinical Implications of Negatively Adjudicated Heart Failure Events: Data From the VICTORIA Study
5. Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan
6. Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure: The COSMIC-HF Trial
7. Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients With Chronic Heart Failure: Results From the COSMIC-HF Study
8. Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan
9. Racial Differences in Serial NT-proBNP Levels in Heart Failure Management: Insights From the GUIDE-IT Trial
10. Heart Failure Clinical Trial Operations During the COVID-19 Pandemic: Results From a Multicenter Survey
11. Challenges and Potential Improvements to Patient Access to Pharmaceuticals: Examples From Cardiology
12. Obese-Inflammatory Phenotypes in Heart Failure With Preserved Ejection Fraction
13. Biomarkers in Advanced Heart Failure: Implications for Managing Patients With Mechanical Circulatory Support and Cardiac Transplantation
14. Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure
15. Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT Trial
16. Building the Foundation for a New Era of Quadruple Therapy in Heart Failure
17. Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function
18. Trends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure: Insights From the Get With The Guidelines–Heart Failure Registry
19. Considering the duration of heart failure: using the past to predict the future
20. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND‐HF
21. Whatʼs Next for Acute Heart Failure Research?
22. Abstract 17332: A Multi-Marker Approach for Risk Stratification in Patients With Chronic Heart Failure: Insights From the HF-ACTION Trial
23. Abstract 17298: Comparative Effectiveness of Sulfonylurea versus Metformin in Patients With Heart Failure and Diabetes Mellitus
24. Abstract 17194: High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure and a Preserved Ejection Fraction - Insights From the Heart Failure Network
25. Abstract 15360: Biomarker-Guided Heart Failure Therapy Results in Significant Reverse Left Ventricular Remodeling Among Patients Achieving NT-proBNP Goal: Insights From the GUIDE-IT Trial
26. Abstract 15020: Treatment With Omecamtiv Mecarbil, a Cardiac Myosin Activator, Improves NT-proBNP in Patients With Chronic Heart Failure: A Responder Analysis From COSMIC-HF
27. Plasma Levels of MicroRNA-155 Are Upregulated with Long-Term Left Ventricular Assist Device Support
28. Inpatient Management of Heart Failure: Are We Shooting at the Right Target?
29. Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure
30. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
31. Augmenting outcomes in patients with advanced heart failure
32. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
33. Supplement to: Diuretic strategies in patients with acute decompensated heart failure.
34. Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial
35. Natriuretic peptide-guided heart failure management
36. Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
37. Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF
38. Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial
39. Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)
40. Association between adrenergic receptor genotypes and beta-blocker dose in heart failure patients: analysis from the HF-ACTION DNA substudy
41. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study
42. Successful Organ Donation After Long-Term Circulatory Support With Nonpulsatile Mechanical Support
43. Link between decisions regarding resuscitation and preferences for quality over length of life with heart failure
44. Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF
45. Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
46. Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study
47. Red blood cell distribution width and 1-year mortality in acute heart failure
48. Vasodilators in the treatment of acute heart failure: What we know, what we donʼt
49. Relaxin, a pleiotropic vasodilator for the treatment of heart failure
50. Early worsening heart failure in patients admitted with acute heart failure - a new outcome measure associated with long-term prognosis?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.